Trade

Syngene International share price

Moderate risk
  • 24%Low risk
  • 24%Moderate risk
  • 24%Balanced risk
  • 24%High risk
  • 24%Extreme risk
  • ₹633.30(0.98%)
    December 10, 2025 11:40:19 AM IST
    • NSE
    • BSE
  • Vol : 109.44 K (NSE + BSE)
    Last 20 day avg : 486.67 K

Syngene International is trading 0.98% upper at Rs 633.30 as compared to its last closing price. Syngene International has been trading in the price range of 634.30 & 627.40. Syngene International has given -26.94% in this year & -1.59% in the last 5 days. There are 8 analysts who have initiated coverage on Syngene International. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 67.10 Crores in its last quarter.Listed peers of Syngene International include Divi's Laboratories (1.47%), Dr Reddy's Laboratories (0.55%), Cipla (0.14%).The Mutual Fund holding in Syngene International was at 21.22% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Syngene International was at 16.31% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 10, 2025, 06:24 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.83
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.20
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.37
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    54.43
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    6.91
    Indicates overvaluation
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
627.40
Highest
634.30
52 week range
Lowest
598.55
Highest
917.95
Syngene International News
Syngene International Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Neutral
6,384.551.471,69,468.2078.2711.470.460.01
Dr Reddy's Laboratories
Neutral
1,253.050.551,04,397.2118.803.170.632.34
Cipla
Bearish
1,492.750.141,20,580.0423.333.940.850.81
Torrent Pharmaceuticals
Bullish
3,777.000.371,27,946.4166.6416.920.8417.62
Sun Pharmaceutical Industries
Neutral
1,778.000.104,26,531.3237.946.040.880.50
Mutual Fund Ownership
View all
LIC MF Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 2.55
  • % of AUM 3.02
Mirae Asset Focused Fund Regular Growth
2/5
  • Amount Invested (Cr.) 223.16
  • % of AUM 2.82
DSP Multicap Fund Regular Growth
NA
  • Amount Invested (Cr.) 57.65
  • % of AUM 2.55
DSP Focused Fund Growth
3/5
  • Amount Invested (Cr.) 63.83
  • % of AUM 2.48
Nippon India Innovation Fund Regular Growth
NA
  • Amount Invested (Cr.) 63.40
  • % of AUM 2.47
Syngene International Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-05Quarterly Results
2025-07-23Quarterly Results
2025-04-23Audited Results & Final Dividend
2025-01-23Quarterly Results
2024-10-23Quarterly Results
About the company Syngene International
  • IndustryBiotechnology & Drugs
  • ISININE398R01022
  • BSE Code539268
  • NSE CodeSYNGENE
Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Company's services include discovery, development, manufacturing, SynVent Integrated Drug discovery, dedicated centers, and Center for Advanced Protein Studies (CAPS). Its discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. It offers preclinical development, active pharmaceutical ingredient and drug product development for both small molecules and biologics. It has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. SynVent is its drug discovery platform for enabling fully integrated therapeutic drug discovery and development across small molecules, new modalities and biologics.
  • Management Info
  • Peter BainsChief Executive Officer, Managing Director, Additional Director
  • Deepak JainChief Financial Officer
  • Andrew WebsterChief Human Resources Officer
  • Kenneth BarrSenior Vice President - Research Services
  • Alex Del PrioreSenior Vice President - Manufacturing Services
  • Gaurav KushwahaChief Technology Officer
  • Jayashree AiyarChief Scientific Officer
  • Chethan YogeshCompliance Officer, Company Secretary
  • Pramuch GoelHead of Corporate Affairs
  • Caroline HempsteadHead of Customer Centricity and Special Projects
Syngene International Share Price FAQs

Syngene International is trading at 633.30 as on Wed Dec 10 2025 06:10:19. This is 0.98% upper as compared to its previous closing price of 627.15.

The market capitalization of Syngene International is 25439.06 Cr as on Wed Dec 10 2025 06:10:19.

The average broker rating on Syngene International is Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 3 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 2 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Syngene International is 917.95 whereas the 52 wk low is 598.55

Syngene International can be analyzed on the following key metrics -

  • TTM P/E: 53.46
  • Sector P/E: -
  • Dividend Yield: 0.20%
  • D/E ratio: 0.12

Syngene International reported a net profit of 496.20 Cr in 2025.

The Mutual Fund Shareholding was 21.22% at the end of 30 Sep 2025.

Quick Links
EQUITY QUICK LINKS
Syngene International QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Syngene International share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.